Cisen Pharmaceutical Co., Ltd. (603367.SS)

CNY 14.05

(0.0%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 7.33 Billion 6.81 Billion 6.36 Billion 6.16 Billion 5.53 Billion 5.24 Billion
Total Current Assets 4.96 Billion 4.74 Billion 4.14 Billion 3.95 Billion 3.78 Billion 3.59 Billion
Cash And Short Term Investments 2.62 Billion 2.54 Billion 2.42 Billion 2.53 Billion 2.35 Billion 360.09 Million
Cash and Cash Equivalents 983.38 Million 997.94 Million 938.97 Million 661.41 Million 382.41 Million 345.76 Million
Short Term Investments 1.63 Billion 1.54 Billion 1.48 Billion 1.87 Billion 1.97 Billion 14.33 Million
Net Receivables 1.36 Billion 1.36 Billion 1.09 Billion 835.15 Million 798.82 Million 760.02 Million
Inventory 708.21 Million 580.43 Million 594.64 Million 572.11 Million 600.89 Million 661.82 Million
Other Current Assets 157.73 Million 248.45 Million 31.97 Million 6.29 Million 23.73 Million 1.81 Billion
Total Non-Current Assets 2.36 Billion 2.07 Billion 2.21 Billion 2.21 Billion 1.75 Billion 1.65 Billion
Net PPE 1.39 Billion 1.48 Billion 1.59 Billion 1.63 Billion 1.34 Billion 1.28 Billion
Good Will And Intangible Assets 211.59 Million 213.03 Million 210.82 Million 207.91 Million 208.01 Million 188.98 Million
Good Will - - - - - -
Intangible Assets 211.59 Million 213.03 Million 210.82 Million 207.91 Million 208.01 Million 188.98 Million
Long-Term Investments 5.93 Million -1.52 Billion -1.45 Billion -1.82 Billion -1.92 Billion 42.87 Million
Tax Assets 79.82 Million 86.71 Million 81.65 Million 63.11 Million 65.58 Million 72.56 Million
Other Non Current Assets 679.99 Million 1.8 Billion 1.79 Billion 2.12 Billion 2.05 Billion 62.59 Million
Other Assets - 1.00 1.00 1.00 1.00 1.00
Total Liabilities 1.57 Billion 1.45 Billion 1.3 Billion 1.36 Billion 959.97 Million 1.09 Billion
Total Current Liabilities 1.36 Billion 1.28 Billion 1.21 Billion 1.28 Billion 885.53 Million 1 Billion
Account Payables 468 Million 459.71 Million 434.96 Million 502.13 Million 390.59 Million 491.68 Million
Tax Payables 91.24 Million 86.7 Million 76.7 Million 93.07 Million 56.66 Million 36.62 Million
Short Term Debt 38.14 Million 58.09 Million 132.72 Million 330 Million 100 Million 129.25 Million
Deferred Revenue 559.37 Million 118.78 Million 403.42 Million 443.05 Million 310.21 Million 102.33 Million
Other Current Liabilities 304.39 Million 645.33 Million 247.82 Million 9.16 Million 84.72 Million 284.7 Million
Total Non Current Liabilities 201.46 Million 177.32 Million 89.2 Million 79.41 Million 74.43 Million 85.4 Million
Long-Term Debt 132.53 Million 100.51 Million 10.9 Million 1.04 Million 1.00 -
Deferred Revenue Non Current 56.25 Million 65.35 Million 74.42 Million 75.01 Million 71.66 Million 85.4 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.00 - 1.00 -1.04 Million - -4.05 Million
Other Liabilities 1.00 1.00 1.00 1.00 - -
Total Equity 5.76 Billion 5.35 Billion 5.05 Billion 4.8 Billion 4.57 Billion 4.15 Billion
Stock Holders Equity 5.72 Billion 5.33 Billion 5.05 Billion 4.8 Billion 4.57 Billion 4.15 Billion
Common Stock 452.77 Million 453.31 Million 453.33 Million 453.35 Million 453.35 Million 453.35 Million
Retained Earnings 3.13 Billion 2.76 Billion 2.54 Billion 2.32 Billion 2.01 Billion 1.6 Billion
Accumulated other comprehensive income -2.68 Million 217.31 Million 199.06 Million 175.73 Million 226.61 Million 215.83 Million
Common Stock Equity 5.72 Billion 5.33 Billion 5.05 Billion 4.8 Billion 4.57 Billion 4.15 Billion
Capital Lease Obligation 4.03 Million 512.22 Thousand 10.9 Million 1.04 Million - -
Total Investments 5.93 Million 24.75 Million 25.64 Million 53.2 Million 52.98 Million 57.2 Million
Total Debt 170.67 Million 158.6 Million 143.63 Million 330 Million 100 Million 129.25 Million
Net Debt -812.71 Million -839.34 Million -795.34 Million -331.41 Million -282.41 Million -216.51 Million

Balance Sheet Charts